Author Question: A researcher develops a study to examine the effects of Keep Yourself Safe Screening (KYSS) on the ... (Read 84 times)

K@

  • Hero Member
  • *****
  • Posts: 608
A researcher develops a study to examine the effects of Keep Yourself Safe Screening (KYSS) on the incidence of intimate partner violence (IPV). The study level of significance is 0.05.
 
  The null hypothesis, that KYSS will have no effect on IPV, is found to be true. When reviewing the study for Type II errors, the reviewer understands that:
  a. a level of significance of 0.01 would decrease the risk of a Type II error.
  b. the level of significance does not affect the chance of a Type II error.
  c. there is a 5 chance that the null hypothesis is false.
  d. there is a 5 chance that the null hypothesis is true.

Question 2

When a researcher concludes that study findings are applicable to the total population, this is an example of
 
  a. generalization.
  b. inference.
  c. probability.
  d. significance.



ynlevi

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

ANS: C

Answer to Question 2

ANS: A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library